Lung cancer is a highly
heterogeneous disease in terms of both underlying genetic lesions and response
to therapeutic treatments. We performed deep whole-genome sequencing and
transcriptome sequencing on 19 lung cancer cell lines and three lung
tumor/normal pairs. Overall, our data show that cell line models exhibit
similar mutation spectra to human tumor samples. Smoker and never-smoker cancer
samples exhibit distinguishable patterns of mutations. A number of epigenetic
regulators, including KDM6A, ASH1L, SMARCA4, and ATAD2, are frequently altered
by mutations or copy number changes. A systematic survey of splice-site
mutations identified 106 splice site mutations associated with cancer specific
aberrant splicing, including mutations in several known cancer-related genes.
RAC1b, an isoform of the RAC1 GTPase that includes one additional exon, was
found to be preferentially up-regulated in lung cancer. We further show that
its expression is significantly associated with sensitivity to a MAP2K (MEK)
inhibitor PD-0325901. Taken together, these data present a comprehensive
genomic landscape of a large number of lung cancer samples and further
demonstrate that cancer-specific alternative splicing is a widespread
phenomenon that has potential utility as therapeutic biomarkers. The detailed
characterizations of the lung cancer cell lines also provide genomic context to
the vast amount of experimental data gathered for these lines over the decades,
and represent highly valuable resources for cancer biology.
Source: Genome
and transcriptome sequencing of lung cancers reveal diverse mutational and
splicing events. Liu J, Lee W, Jiang Z, Chen Z, Jhunjhunwala S, Haverty PM,
Gnad F, Guan Y, N Gilbert H, Stinson J, Klijn C, Guillory J, Bhatt D, Vartanian
S, Walter K, Chan J, Holcomb T, Dijkgraaf P, Johnson S, Koeman J, Minna JD,
Gazdar AF, Stern HM, Hoeflich KP, Wu TD, Settleman J, de Sauvage FJ, Gentleman
RC, Neve RM, Stokoe D, Modrusan Z, Seshagiri S, Shames DS, Zhang Z (zhang.zemin@gene.com). Genome Res. 2012
Nov 1.
Free paper available at:
Aucun commentaire:
Enregistrer un commentaire